Literature DB >> 11438476

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis.

M Guidoboni1, R Gafà, A Viel, C Doglioni, A Russo, A Santini, L Del Tin, E Macrì, G Lanza, M Boiocchi, R Dolcetti.   

Abstract

Colorectal cancers with high-frequency microsatellite instability show peculiar clinicopathological features and a favorable clinical outcome. We investigated whether the improved prognosis for these cancers is related to the content of activated cytotoxic intraepithelial T lymphocytes. Microsatellite instability and the amount of activated cytotoxic lymphocytes were analyzed according to clinicopathological features, survival, and disease recurrence in 109 right-sided colon carcinomas from 245 consecutive patients with stage II/III colon cancer that underwent radical surgery. High-frequency microsatellite instability was found in 43% of stage II/III proximal colon cancers and was associated with significantly higher numbers of activated cytotoxic lymphocytes. High-frequency microsatellite instability, as well as the content of intratumoral-activated cytotoxic T lymphocytes correlated with improved overall and disease-free survival, particularly in patients with stage III tumors. Multivariate analysis revealed that patients with both features had a risk of death and relapse markedly lower than that associated with microsatellite status or intratumoral cytotoxic lymphocytes separately. The presence of local cytotoxic immune responses is probably the major determinant of the good clinical course of patients with microsatellite unstable colon cancer. Furthermore, high-frequency microsatellite instability coupled with a high content of intratumoral cytotoxic lymphocytes may identify a subset of colon cancer patients with a favorable clinical outcome, particularly in stage III disease.

Entities:  

Mesh:

Year:  2001        PMID: 11438476      PMCID: PMC1850401          DOI: 10.1016/S0002-9440(10)61695-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

Authors:  H Elsaleh; D Joseph; F Grieu; N Zeps; N Spry; B Iacopetta
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

2.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

3.  Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

Authors:  R Gryfe; H Kim; E T Hsieh; M D Aronson; E J Holowaty; S B Bull; M Redston; S Gallinger
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

Review 4.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.

Authors:  C M Wright; O F Dent; M Barker; R C Newland; P H Chapuis; E L Bokey; J P Young; B A Leggett; J R Jass; G A Macdonald
Journal:  Br J Surg       Date:  2000-09       Impact factor: 6.939

6.  Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.

Authors:  G Lanza; R Gafà; M Matteuzzi; A Santini
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

7.  Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.

Authors:  A Hemminki; J P Mecklin; H Järvinen; L A Aaltonen; H Joensuu
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

8.  Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.

Authors:  G Lanza; R Gafà; A Santini; I Maestri; A Dubini; G Gilli; L Cavazzini
Journal:  Cancer       Date:  1998-01-01       Impact factor: 6.860

9.  Microsatellite instability in cancer of the proximal colon.

Authors:  S N Thibodeau; G Bren; D Schaid
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

10.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.

Authors:  Y Ionov; M A Peinado; S Malkhosyan; D Shibata; M Perucho
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

View more
  99 in total

1.  Microsatellite instability in colorectal cancer: prognostic, predictive or both?

Authors:  Marius van Rijnsoever; Hany Elsaleh; Barry Iacopetta
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Authors:  Katsuhiko Nosho; Yoshifumi Baba; Noriko Tanaka; Kaori Shima; Marika Hayashi; Jeffrey A Meyerhardt; Edward Giovannucci; Glenn Dranoff; Charles S Fuchs; Shuji Ogino
Journal:  J Pathol       Date:  2010-12       Impact factor: 7.996

3.  Clinicopathologic features and prognostic analysis of MSI-high colon cancer.

Authors:  Chun-Chi Lin; Yi-Ling Lai; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kai Jiang; Shung-Haur Yang; Huann-Sheng Wang; Yuan-Tzu Lan; Wen-Yih Liang; Hui-Mei Hsu; Jen-Kou Lin; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2011-11-12       Impact factor: 2.571

4.  Histotype-based prognostic classification of gastric cancer.

Authors:  Anna Maria Chiaravalli; Catherine Klersy; Alessandro Vanoli; Andrea Ferretti; Carlo Capella; Enrico Solcia
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 5.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

6.  Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.

Authors:  Moritz Koch; Philipp Beckhove; Jan Op den Winkel; Daniel Autenrieth; Philipp Wagner; Daniel Nummer; Sebastian Specht; Dalibor Antolovic; Luis Galindo; Friedrich H Schmitz-Winnenthal; Volker Schirrmacher; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

7.  Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.

Authors:  J M Carethers
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 8.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.

Authors:  Sara Michel; Michael Linnebacher; Joshua Alcaniz; Maike Voss; Rudolf Wagner; Wolfgang Dippold; Christina Becker; Magnus von Knebel Doeberitz; Soldano Ferrone; Matthias Kloor
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

10.  Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.

Authors:  Isabel Maleno; Carmen Maria Cabrera; Teresa Cabrera; Laura Paco; Miguel Angel López-Nevot; Antonia Collado; Antonio Ferrón; Federico Garrido
Journal:  Immunogenetics       Date:  2004-07-16       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.